Personnel Information

写真a

MIURA Osamu


Mail Address

miura.hema@tmd.ac.jp

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1980.03, Graduated

Campus Career 【 display / non-display

  • 2000.04
    -
    2016.08
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Hematology, Professor

Research Areas 【 display / non-display

  • Hematology

 

Published Papers & Misc 【 display / non-display

  • Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019.09; 33 (5): 1599-1604. ( PubMed, DOI )

  • Masahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, Toshikage Nagao, Shigeo Toyota, Osamu Miura. Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy. Anticancer Res.. 2019.09; 39 (9): 5115-5122. ( PubMed, DOI )

  • Kouhei Yamamoto, Shinya Abe, Ayaka Honda, Jun Hashimoto, Yuuki Aizawa, Sachiko Ishibashi, Taro Takemura, Nobutaka Hanagata, Masahide Yamamoto, Osamu Miura, Morito Kurata, Masanobu Kitagawa. Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Lab. Invest.. 2019.09; ( PubMed, DOI )

  • Hiroki Akiyama, Yoshihiro Umezawa, Shinya Ishida, Keigo Okada, Ayako Nogami, Osamu Miura. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress. Cancer Lett.. 2019.04; 453 84-94. ( PubMed, DOI )

  • Emi Uchida, Shihoko Suwa, Ryoto Yoshimoto, Ken Watanabe, Takeshi Kasama, Osamu Miura, Tetsuya Fukuda. TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation. Int. J. Oncol.. 2019.03; ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • Yoshihiro Umezawa, ken Watanabe, Toshikage Nagao, Chizuko Sakashita, Ayako Nogami, Norihiko Kawamata, Osamu Miura, Masahide Yamamoto. Achieving deep molecular response after first-line TKI therapy for CML. The 80th annual meeting of the japanese society of hematology 2018.10.12 Osaka

  • Gaku Oshikawa, Yoshihiro Umezawa, Aiko Igarashi, Kazuhiko Kakihana, Kazuteru Ohashi, Norihiko Kawamata, Osamu MIura, Masahide Yamamoto. Impact of azacitidine for oligoblastic AML ineligible for stem cell transplantation. The 80th annual meeting of Japanese society of hematology 2018.10.12 Osaka

  • Ayako Nogami, Keigo Okada, Daisuke Watanabe, Hiroki Akiyama, Yoshihiro Umezawa, Shinya Ishida, Gaku Oshikawa, Shuji Tohda, Osamu Miura . Proteasome Inhibitors Downregulate the mTORC1/4EBP1/S6K/Mcl-1 Pathway Cooperatively with Inhibitors for The STAT5/Pim Kinase Pathway to Induce Apoptosis in FLT3-ITD-positive AML Cells. The 9th JSH International Symposium 2018 2018.07.28 Kyoto

  • Hiroki Akiyama, Yoshihiro Umezawa, Keigo Okada, Daisuke Watanabe, Shinya Ishida, Ayako Nogami, Osamu Miura. Deubiquitinase Inhibitor WP1130 Exerts Anti-leukemic Effect by Causing Aggresomal Translocation of FLT3-ITD and Oxidative Stress to Induce Apoptosis. The 9th JSH International Symposium 2018 2018.07.27 Kyoto

  • 池田朱里、堤大樹、渡邉健、青山慧、齋藤達也、長尾俊景、坂下千瑞子、山本正英、福田哲也、東田修二、新井文子、川又紀彦、三浦修.. 二次性骨髄線維症による門脈圧亢進症性消化管出血に対してルキソリチニブが著効した一例. 日本血液学会関東甲信越地方会 2018.03.03 東京

display all >>